1. Xihui Liu, Suryavathi Viswanadhapalli, Shourya Kumar, Tae-Kyung Lee, Andrew Moore, Shihong Ma, Liping Chen, Michael Hsieh, Mengxing Li, Gangadhara R Sareddy, Karla Parra, Eliot Blatt, Tanner C. Reese, Yuting Zhao, Hui Yan, Zhenming Xu, Uday P Pratap, Carlos Roggero, Yan Peng, Rajeshwar Rao Tekmal, Carlos Arteaga, Jennifer Lippincott-Schwartz, Ratna K. Vadlamudi,* Jung-Mo Ahn,* and Ganesh V. Raj,* Identification of Lysosomal Acid Lipase A as a novel molecular vulnerability in triple negative breast cancer. Nature Cancer, 2022, in print. doi: 10.1038/s43018-022-00389-8. PMID: 35654861.
  2. Tae-Kyung Lee, Bikash Manandhar, Kara Kassees and Jung-Mo Ahn, Peptide ligation via Suzuki-Miyaura cross-coupling reaction. Org. Chem. 2020, 85, 1376-1384. doi: 10.1021/acs.joc.9b02313. PMID: 31773962.
  3. Lingling Duan, Zhenhua Chen, Jun Lu, Yanping Liang, Ming Wang, Carlos Roggero, Qing-Jun Zhang, Jason Gao, Yong Fang, Jiazheng Cao, Jian Lu, Hongwei Zhao, Andrew Dang, Rey-Chen Pong, Elizabeth Hernandez, Chun-Mien Chang, David T. Hoang, Jung-Mo Ahn, Guanghua Xiao, Ruitao Wang, Kaijiang Yu, Payal Kapur, Josep Rizo, Jer-Tsong Hsieh, Junhang Luo, and Zhi-Ping Liu. Histone lysine demethylase KDM4B regulates the alternative splicing of the androgen receptor in castration resistant prostate cancer. Nucleic Acid Res. 2019, 47, 11623-11636. doi: 10.1093/nar/gkz1004.  PMID: 31647098, PMCID: PMC7145715.
  4. Suryavathi Viswanadhapalli, Shihong Ma, Gangadhara Reddy Sareddy, Tae-Kyung Lee, Mengxing Li, Collin Gilbreath, Xihui Liu, Yiliao Luo, Uday P. Pratap, Mei Zhou, Eliot B. Blatt, Kara Kassees, Carlos Arteaga, Prasanna Alluri, Manjeet Rao, Susan T. Weintraub, Rajeshwar Rao Tekmal, Jung-Mo Ahn,* Ganesh V. Raj,* and Ratna K. Vadlamudi,* Estrogen receptor coregulator binding modulator (ERX-11) enhances the activity of CDK4/6 inhibitors against estrogen receptor-positive breast cancers. Breast Cancer Res. 2019, 21, 150. doi: 10.1186/s13058-019-1227-8. PMID: 31878959, PMCID: PMC6933697.
  5. Tae-Kyung Lee, Preethi Ravindranathan, Rajni Sonavane, Ganesh V. Raj, and Jung-Mo Ahn, A structure-activity relationship study of bis-benzamides as inhibitors of androgen receptor-coactivator interaction. Molecules 2019, 24 (15), 2783. doi:10.3390/molecules24152783. PMID: 31370197. PMCID: PMC6696232.
  6. Justin Goodwin, Hyunsung Choi, Meng-hsiung Hsieh, Michael L. Neugent, Jung-Mo Ahn, Heather N. Hayenga, Pankaj K. Singh, David B. Shackelford, In-Kyu Lee, Vladimir Shulaev, Shanta Dhar, Norihiko Takeda, and Jung-whan Kim. Targeting Hypoxia-Inducible Factor-1α/Pyruvate Dehydrogenase Kinase 1 Axis by Dichloroacetate Suppresses Bleomycin-induced Pulmonary Fibrosis. J. Respir. Cell Mol. Biol.2018, 58, 216-231. doi:10.1165/rcmb.2016-0186OC. PMID: 28915065, PMCID: PMC5805994.
  7. Justin Goodwin, Michael Neugent, Shin Yup Lee, Joshua Choe, Hyunsung Choi, Dana Jenkins, Robin Ruthenborg, Maddox Robinson, Ji Yun Jeong, Masaki Wake, Hajime Abe, Norihiko Takeda, Hiroko Endo, Masahiro Inoue, Zhenyu Xuan, Hyuntae Yoo, Min Chen, Jung-Mo Ahn, John Minna, Kristi Helke, Pankaj Singh, David Shackelford, and Jung-whan Kim, The Distinct Metabolic Phenotype of Lung Squamous Cell Carcinoma Defines Selective Vulnerability to Glycolytic Inhibition. Nature Communications, 2017, 8, 15503. doi:10.1038/ncomms15503. PMID: 28548087, PMCID: PMC5458561.
  8. Ganesh V. Raj, Gangadhara Reddy Sareddy, Shihong Ma, Tae-Kyung Lee, Suryavathi Viswanadhapalli, Rui Li, Xihui Liu, Shino Murakami, Chien-Cheng Chen, Wan-Ru Lee, Monica Mann, Samaya Rajeshwari Krishnan, Bikash Manandhar, Vijay K. Gonugunta, Douglas Strand, Rajeshwar Rao Tekmal, Jung-Mo Ahn, and Ratna K. Vadlamudi, Estrogen receptor coregulator binding modulators (ERXs) effectively target estrogen receptor positive human breast cancers. eLife 2017, 6, e26857. doi:10.7554/eLife.26857. PMID: 28786813, PMCID: PMC5548489.
  9. Justin Goodwin, Michael Neugent, Shin Yup Lee, Joshua Choe, Hyunsung Choi, Dana Jenkins, Robin Ruthenborg, Maddox Robinson, Ji Yun Jeong, Masaki Wake, Hajime Abe, Norihiko Takeda, Hiroko Endo, Masahiro Inoue, Zhenyu Xuan, Hyuntae Yoo, Min Chen, Jung-Mo Ahn, John Minna, Kristi Helke, Pankaj Singh, David Shackelford, and Jung-whan Kim, The Distinct Metabolic Phenotype of Lung Squamous Cell Carcinoma Defines Selective Vulnerability to Glycolytic Inhibition. Nature Communications 2017, 8, 15503. doi:10.1038/ncomms15503. PMID: 28548087, PMCID: PMC5458561.
  10. Jung-Mo Ahn, Kara Kassees, Tae-Kyung Lee, Bikash Manandhar, and Ali M. Yousif. Strategy and Tactics for Designing Analogs: Biochemical Characterization of the Large Molecules. Comprehensive Medicinal Chemistry, 3rd Edition, Vol. 6, V. Srivastava (Ed.), Elsevier, Oxford, UK. pp.1-50 (2017) doi:10.1016/B978-0-12-409547-2.12413-8.
  11. Chris de Graaf, Dan Donnelly, Denise Wootten, Jesper Lau, Patrick M. Sexton, Laurence J. Miller, Jung-Mo Ahn, Jiayu Liao, Madeleine M. Fletcher, Dehua Yang, Alastair J. H. Brown, Caihong Zhou, Jiejie Deng, and Ming-Wei Wang, Glucagon-like peptite-1 and its class B G protein-coupled receptors: a long march to therapeutic successes. Pharmacol. Rev. 2016, 68, 954-1013. doi:10.1124/pr.115.011395. PMID:27630114, PMCID:PMC5050443.
  12. Corey Toocheck, Terri Clister, John Shupe, Chelsea Crum, Preethi Ravindranathan, Tae-Kyung Lee, Jung-Mo Ahn, Ganesh V. Raj, Meena Sukhwani, Kyle E. Orwig, and William H. Walker, Mouse Spermatogenesis Requires Classical And Non-classical Testosterone Signaling. Biol. Reprod. 2016, 94, 1-14. doi:10.1095/​biolreprod.115.132068. PMID:26607719, PMCID:PMC4809556.
  13. Tzu-Fang Lou, Deepa Sethuraman, Patrick Dospoy, Pallevi Srivastva, Hyun Seok Kim, Joongsoo Kim, Xiaotu Ma, Pei-Hsuan Chen, Kenneth E. Huffman, Robin E. Frink, Jill E. Larsen, Cheryl M. Lewis, Sang-Won Um, Duk-Hwan Kim, Jung-Mo Ahn, Ralph J. DeBerardinis, Michael White, John D. Minna, and Hyuntae Yoo, Cancer-specific production of N-acetylaspartate via NAT8L overexpression in non-small cell lung cancer and its potential as a circulating biomarker. Cancer Prev. Res. 2016, 9, 43-52. doi:10.1158/1940-6207.CAPR-14-0287. PMID:26511490, PMCID:PMC4774047. (Epub 2015 Oct 28)
  14. Tae-Kyung Lee, Bikash Manandhar, and Jung-Mo Ahn, Peptide ligation via Suzuki-Miyaura cross-coupling reaction. Proceedings of the 24thAmerican Peptide Symposium. V. Srivasatava, A. Yudin, M. Lebl, Eds., American Peptide Society, San Diego, CA, pp.268-269 (2015). doi:10.17952/24APS.2015.268.
  15. Bikash Manandhar, William Silvers, Amit Kumar, Xiankai Sun, and Jung-Mo Ahn, Pancreatic beta-cell imaging with high affinity peptide ligands to the GLP-1 receptor. Proceedings of the 24thAmerican Peptide Symposium. V. Srivasatava, A. Yudin, M. Lebl, Eds., American Peptide Society, San Diego, CA, pp.154-155 (2015). doi:10.17952/24APS.2015.154.
  16. Bikash Manandhar, Tae-Kyung Lee, and Jung-Mo Ahn, Multiple labeling of peptides via orthogonal coupling reactions and its application.Proceedings of the 24thAmerican Peptide Symposium. V. Srivasatava, A. Yudin, M. Lebl, Eds., American Peptide Society, San Diego, CA, pp.270-271 (2015). doi:10.17952/24APS.2015.270.
  17. Joongsoo Kim, Rakesh Kumar, and Jung-Mo Ahn, Tris-benzamide analogs for inhibiting Bcl-2 proteins in prostate cancer. Proceedings of the 24thAmerican Peptide Symposium. V. Srivasatava, A. Yudin, M. Lebl, Eds., American Peptide Society, San Diego, CA, pp.170-171 (2015). doi:10.17952/24APS.2015.170.
  18. Bikash Manandhar and Jung-Mo Ahn, Glucagon-like Peptide-1 (GLP-1) Analogs: Recent Advances, New Possibilities, and Therapeutic Implications. J. Med. Chem. 2015, 58, 1020-1037. doi:10.1021/jm500810s. PMID:25349901, PMCID:PMC4329993.
  19. Omar N. Akram, David J. DeGraff, Jonathan H. Sheehan, Wayne D. Tilley, Robert J. Matusik, Jung-Mo Ahn, and Ganesh V. Raj, Tailoring Peptidomimetics for Targeting Protein-protein Interactions. Mol. Cancer Res. 2014, 12, 967-978. doi:10.1158/1541-7786.MCR-13-0611. PMID:24642350.
  20. Magdalenda M. Grabowska, Amicia D. Elliott, David J. DeGraff, Philip D. Anderson, Govindaraj Anumanthan, Hironobu Yamashita, Qian Sun, David B. Friedman, David L. Hachey, Xiuping Yu, Jonathan H. Sheehan, Jung-Mo Ahn, Ganesh V. Raj, David W. Piston. Richard M. Gronostajski, Robert J. Matusik, Nuclear Factor One Transcription Factors Interact with FOXA1 to Regulate Prostate Specific Gene Expression, Mol. Endocrinol. 2014, 28, 949-964. doi:10.1210/me.2013-1213. PMID:24801505, PMCID:PMC4042066.
  21. Tae-Kyung Lee, Bikash Manandhar, and Jung-Mo Ahn, Exploration of the scope of Suzuki-Miyaura cross-coupling in peptide ligation. Peptides: Peptides Across the Pacific, Proceedings of the 23rdAmerican Peptide Symposium. M. Lebl, Ed., American Peptide Society, San Diego, CA, pp. 234-235 (2013). doi: 10.17952/23APS.2013.234.
  22. Bikash Manandhar, Su-Tang Lo, Eunice Murage, Mai Lin, Xiankai Sun, and Jung-Mo Ahn, Targeting GLP-1R for non-invasive assessment of pancreatic b-cell mass. Peptides: Peptides Across the Pacific, Proceedings of the 23rdAmerican Peptide Symposium. M. Lebl, Ed., American Peptide Society, San Diego, CA, pp. 172-173 (2013). doi: 10.17952/23APS.2013.172.
  23. Jung-Mo Ahn, Joongsoo Kim, Rakesh Kumar, Kajal Bhimani, Jaspal Singh, Pradeep Patil, Yuefeng Du, Timothy Dobin, Jonathan Nguyen, and Jer-Tsong Hsieh, Rational design of helix-mimicking small molecules for inhibiting BCL-2 proteins in prostate cancer. Peptides: Peptides Across the Pacific, Proceedings of the 23rdAmerican Peptide Symposium. M. Lebl, Ed., American Peptide Society, San Diego, CA, pp. 186-187 (2013). doi:10.17952/23APS.2013.186.
  24. Aniket S. Wadajkar, Jyothi U. Menon, Yuh-Shyan Tsai, Crystal Gore, Timothy Dobin, Leah Gandee, Kim Kangasniemi, Masaya Takahashi, Bikash Manandhar, Jung-Mo Ahn, Jer-Tsong Hsieh, and Kytai T. Nguyen, Prostate Cancer-Specific Thermo-Responsive Polymer-Coated Iron Oxide Nanoparticles, Biomaterials 2013, 34, 3618-3625. doi:10.1016/j.biomaterials.2013.01.062.
  25. Preethi Ravindranathan, Tae-Kyung Lee, Ling Yang, Margaret M. Centenera, Lisa Butler, Wayne D. Tilley, Jer-Tsong Hsieh, Jung-Mo Ahn, and Ganesh V. Raj, Peptidomimetic targeting of critical androgen receptor-coregulator interactions in prostate cancer, Nature Communications 2013, 4, 1923. doi:10.1038/ncomms2912. PMID:23715282.
  26. Tae-Kyung Lee and Jung-Mo Ahn, Stereoselective cycloaddition reactions. Stereoselective Synthesis of Drugs and Natural Products, Vasyl Andrushko and Natalia Andrushko (Eds.), Wiley, pp. 441-474 (2013). doi: 10.1002/9781118596784.ssd016.
  27. Levi Makala, Salvatore Di Maro, Tzu-Fang Lou, Sharanya Sivanand, Jung-Mo Ahn, and Betty S. Pace, FK228 Analogues Induce Fetal Hemoglobin in Human Erythroid Progenit. Anemia 2012, 1-13. doi:10.1155/2012/428137.
  28. Sudipa Saha Roy, Dimple Chakravarty,Cortez Valerie, Keya De Mukhopadhyay, AbhikBandyopadhyay, Jung-Mo Ahn, Ganesh V. Raj, Rajeshwar R. Tekmal, LuZhe Sun, and Ratna K Vadlamudi,Significance of PELP1 in ER-Negative Breast Cancer Metastasis. Mol. Cancer Res. 2012, 10, 25-33. doi:10.1158/1541-7786.MCR-11-0456. PMID:22086908, PMCID:PMC3262052.
  29. Jung-Mo Ahn, Oligo-Benzamides: Versatile Scaffolds to Mimic Protein Helical Surfaces. Peptides: Building Bridges, Proceedings of the 22ndAmerican Peptide Symposium. M. Lebl, Ed., American Peptide Society, San Diego, CA, pp. 178-179 (2011).
  30. Tae-Kyung Lee, Preethi Ravindranathan, Ganesh V. Raj, and Jung-Mo Ahn, Solution- and solid-phase synthesis of bis-benzamide libraries as a-helix mimetics and their evaluation on inhibitory activity to prostate cancer. Peptides: Building Bridges, Proceedings of the 22ndAmerican Peptide Symposium. M. Lebl, Ed., American Peptide Society, San Diego, CA, pp. 180-181 (2011).
  31. Isuru R. Kumarasinghe, Eunice Murage, and Jung-Mo Ahn, Solution structure of a GLP-1 receptor peptidomimetic agonist, Ac-SH3-GLP-1(22-36)-NH2. Peptides: Building Bridges, Proceedings of the 22ndAmerican Peptide Symposium. M. Lebl, Ed., American Peptide Society, San Diego, CA, pp. 182-183 (2011).
  32. Kajal A. Bhimani, Dang Tran, Myoung H. Kim, Rey-Chen Pong, Jer-Tsong Hsieh, and Jung-Mo Ahn, Inhibition of anti-apoptotic Bcl-2 family proteins by tris-benzamides-based a-helix mimetics. Peptides: Building Bridges, Proceedings of the 22ndAmerican Peptide Symposium. M. Lebl, Ed., American Peptide Society, San Diego, CA, pp. 184-185 (2011).
  33. Jung-Mo Ahn, Eunice N. Murage, Su-Tang Lo, Mai Lin, and Xiankai Sun, Highly constrained GLP-1 analogues as non-invasive PET imaging agents for the assessment of pancreatic beta-cell mass. Peptides: Building Bridges, Proceedings of the 22ndAmerican Peptide Symposium. M. Lebl, Ed., American Peptide Society, San Diego, CA, pp. 220-221 (2011).
  34. Haokao Gao, Gang Niu, Min Yang, Qimeng Quan, Ying Ma, Eunice N. Murage, Jung-Mo Ahn, Dale O. Kiesewetter, and Xiaoyuan Chen, PET of Insulinoma using 18F-FBEM-EM3106B, a New GLP-1 Analogue. Pharmaceutics 2011, 8, 1775-1782. doi:10.1021/mp200141x. PMID:21800885, PMCID:PMC3185201.
  35. Su-Tang Lo, Eunice Murage, Jung-Mo Ahn, and Xiankai Sun, PET imaging of pancreatic b-cell mass changes in a mouse model, J. Nucl. Med. 2011, 52(Supplement 1), 86.
  36. Hao Gao, Gang Niu, Min Yang, Qimeng Quan, Ying Ma, Jung-Mo Ahn, Xiankai Sun, Dale Kiesewetter, and Xiaoyuan Chen, PET imaging of insulinoma using 18F-FBEM-EM3106 B, a new GLP-1 analog. J. Nucl. Med. 2011, 52(Supplement 1), 413.
  37. Tae-Kyung Lee and Jung-Mo Ahn, Solid-phase synthesis of tris-benzamides as a-helix mimetics. ACS Comb. Sci. 2011, 13, 107-111. doi:10.1021/co100056c.
  38. Eunice N. Murage, Guangzu Gao, Alessandro Bisello, and Jung-Mo Ahn, Development of potent GLP-1 agonists with high enzyme stability by introducing multiple lactam bridges, J. Med. Chem. 2010, 53, 6412-6420. doi:10.1021/jm100602m.
  39. Srinivasa Marimganti, Murthy N. Cheemala, and Jung-Mo Ahn, Novel Amphiphilic a-Helix Mimetics Based on a Bis-Benzamide Scaffold, Org. Lett. 2009, 11, 4418-4421. doi:10.1021/ol901785v.
  40. Eunice N. Murage, Guangzu Gao, Alessandro Bisello, and Jung-Mo Ahn, Highly constrained glucagon-like peptide-1 with improved biological activity and enzyme stability. Peptides: Breaking Away, Proceedings of the 21stAmerican Peptide Symposium. M. Lebl, Ed., American Peptide Society, San Diego, CA, pp. 144-145 (2009).
  41. Murthy N. Cheemala and Jung-Mo Ahn, Design and synthesis of novel amphiphilic a-helix mimetics based on a new tris-benzamide scaffold. Peptides: Breaking Away, Proceedings of the 21stAmerican Peptide Symposium. M. Lebl, Ed., American Peptide Society, San Diego, CA, pp. 70-71 (2009).
  42. Srinivasa Marimganti, Murthy N. Cheemala, and Jung-Mo Ahn, Synthesis of bis-benzamides as new amphiphilic a-helix mimetics. Peptides: Breaking Away, Proceedings of the 21stAmerican Peptide Symposium. M. Lebl, Ed., American Peptide Society, San Diego, CA, pp. 66-67 (2009).
  43. Tae-Kyung Lee and Jung-Mo Ahn, Efficient solid-phase synthesis of tris-benzamides for a rapid production of a-helix mimetics. Peptides: Breaking Away, Proceedings of the 21stAmerican Peptide Symposium. M. Lebl, Ed., American Peptide Society, San Diego, CA, pp. 74-75 (2009).
  44. Kajal Bhimani, Myoung H. Kim, Jian Zhou, Jer-Tsong Hsieh, and Jung-Mo Ahn, Design and synthesis of a-helix mimetics based on tris-benzamide scaffold to target Bcl proteins. Peptides: Breaking Away, Proceedings of the 21stAmerican Peptide Symposium. M. Lebl, Ed., American Peptide Society, San Diego, CA, pp. 72-73 (2009).
  45. Salvatore Di Maro, Rey-Chen Pong, Jer-Tsong Hsieh, and Jung-Mo Ahn, Structure-activity relationship study of new FK228 analogues as antitumor agents. Peptides: Breaking Away, Proceedings of the 21stAmerican Peptide Symposium. M. Lebl, Ed., American Peptide Society, San Diego, CA, pp. 260-261 (2009).
  46. A. Raji, P. Frycak, C. Temiyasathit, S. B. Kim, G. Mavromaras, J.-M. Ahn, and K. A. Schug, Using multivariate statistical methods to model the pH-dependent ESI response of GXG tripeptides based on multiple physicochemical parameters, Rapid Commun. Mass Spectrom. 2009, 23, 2221-2232. doi:10.1002/rcm.4141.
  47. Salvatore Di Maro and Jung-Mo Ahn, Development of an Efficient Solid Phase Synthetic Methodology to Construct a Combinatorial Library of a Potent HDAC Inhibitor. Peptides: Chemistry, Structure and Biology, Proceedings of the 20thAmerican Peptide Symposium. E. Escher, W. D. Lubell, and S. Del Valle, Eds., Springer, New York, NY, pp.17-18 (2009).
  48. Sun-Young Han, Martin Beinborn, andJung-Mo Ahn, Facile Synthesis of Glucagon-Like Peptide-1 (GLP-1) Mimetics. Peptides: Chemistry, Structure and Biology, Proceedings of the 20thAmerican Peptide Symposium. E. Escher, W. D. Lubell, and S. Del Valle, Eds., Springer, New York, NY, pp.119-120 (2009).
  49. Jung-Mo Ahn,Sung-Young Han, Eunice Murage, and Martin Beinborn, Rational Design of Peptidomimetics for Class B GPCRs: Potent Non-Peptide GLP-1 Receptor Agonists. Peptides: Chemistry, Structure and Biology, Proceedings of the 20thAmerican Peptide Symposium. E. Escher, W. D. Lubell, and S. Del Valle, Eds., Springer, New York, NY, pp.125-126 (2009).
  50. Eunice Murage, Martin Beinborn, andJung-Mo Ahn, Seeking for α-Helical Propensity in a Receptor-Bound Conformation of Glucagon-Like Peptide-1. Peptides: Chemistry, Structure and Biology, Proceedings of the 20thAmerican Peptide Symposium. E. Escher, W. D. Lubell, and S. Del Valle, Eds., Springer, New York, NY, pp.289-290 (2009).
  51. Jung-Mo Ahn and Jeffrey W. Bode, A Bright future for peptide science, Biopolymers: Peptide Science 2008, 90, 480.
  52. Eunice Murage, Jonathan C. Schroeder, Martin Beinborn, and Jung-Mo Ahn, Search for a-helical propensity in the receptor-bound conformation of glucagon-like peptide-1, J. Med. Chem. 2008, 16, 10106-10112. doi:10.1016/j.bmc.2008.10.006.
  53. Salvatore Di Maro, Rey-Chen Pong, Jer-Tsong Hsieh, and Jung-Mo Ahn, Efficient Solid-Phase Synthesis of FK228 Analogues as Potent Antitumoral Agents, J. Med. Chem. 2008, 51, 6639-6641. doi:10.1021/jm800959f.
  54. Srinivasa Marimganti and Jung-Mo Ahn, Acrylic Acid, e-EROS Encyclopedia of Reagents for Organic Synthesis, L. A. Paquette, P. L. Fuchs, G. A. Molander, D. Crich, Eds., Wiley, Chichester, West Sussex, UK, DOI: 10.1002/047084289X.ra035.pub2 (2008).
  55. Srinivasa Marimganti and Jung-Mo Ahn, 2-Chloroacrylonitrile, e-EROS Encyclopedia of Reagents for Organic Synthesis, L. A. Paquette, P. L. Fuchs, G. A. Molander, D. Crich, Eds., Wiley,Chichester, West Sussex, UK,DOI: 10.1002/047084289X.rc069.pub2 (2008).
  56. Jung-Mo Ahn and Sun-Young Han, Facile synthesis of benzamides to mimic an α-helix. Tetrahedron Lett. 2007, 48, 3543-3547. doi:10.1016/j.tetlet.2007.03.108.
  57. A. Raji, P. Frycak, M. Beall, M. Sakrout, J.-M. Ahn, Y. Bao, D.W. Armstrong, K.A. Schug, Development of an ESI-MS Screening Method for Evaluating Binding Affinity between Integrin Fragments and RGD-Based Peptides. Int. J. Mass Spectrom. 2007, 262, 232-240. doi:10.1016/j.ijms.2006.11.015.
  58. Jung-Mo Ahn, Hoyoung Sohn, Yanping Chen, Paul Wentworth Jr., and Kim D. Janda, Mechanistic studies of the conversion of enediynes into quinines. Program No. 570, The International Chemical Congress of Pacific Basin Societies, Honolulu, HI (2005).
  59. Jung-Mo Ahn, Paul Wentworth Jr., and Kim D. Janda, Probing lipase/esterase libraries for lipid A hydrolases – discovery of biocatalysts for the detoxification of bacterially-expressed recombinant protein. Chem. Commun. 2004, 364-365. doi: 10.1039/B312662E.
  60. Jason A. Moss, Avery R. Coyle, Jung-Mo Ahn, Michael Meijler, John Offer, and Kim D. Janda, Tandem IMAC-HPLC Purification of a Cocaine-Binding scFv Antibody. J. Immunol. Methods 2003, 281, 143-148. doi: 10.1016/j.jim.2003.07.010.
  61. Jung-Mo Ahn, Paul Wentworth Jr., and Kim D. Janda, Soluble Polymer-Supported Convergent Parallel Library Synthesis. Chem. Commun. 2003, 480-481.
  62. Jinfa Ying, Jung-Mo Ahn, Neil E. Jacobsen, Michael F. Brown, and Victor J. Hruby, Conformational Study of [desHis1, desPhe6, Glu9]Glucagon Amide by Two Dimensional Nuclear Magnetic Resonance Spectroscopy in the Presence of Perdeuterated Dodecylphosphocholine. Biochemistry 2003, 42, 2825-2835.
  63. Jung-Mo Ahn, Nicholas A. Boyle, Mary T. MacDonald, and Kim D. Janda, Peptidomimetics and Peptide Backbone Modifications. Mini-Rev. Med. Chem. 2002, 2, 463-473.
  64. Karen Moens, Veerle Berger, Jung-Mo Ahn, Chris Van Schravendijk, Victor J. Hruby, Daniel Pipeleers, and Frans Schuit, Assessment of the role of interstitial glucagon in the acute glucose secretory responsiveness of in situpancreatic β-cells. Diabetes 2002, 51, 669-675.
  65. Scott M. Cowell, Preeti M. Balse-Sprinivasan, Jung-Mo Ahn, and Victor J. Hruby, Design and Synthesis of Peptide Antagonists and Inverse Agonists for G Protein-Coupled Receptors. Methods Enzymol. 2002, 343, 49-72.
  66. Jung-Mo Ahn, Dev Trivedi, Peter M. Gitu, Matthew Medeiros, Jennifer R. Swift, and Victor J. Hruby, Positional cyclization scanning: a new method to evaluate the bioactive conformation of glucagon. Peptides: Chemistry, Structure and Biology, Proceedings of the 17thAmerican Peptide Symposium. M. Lebl and R. A. Houghten, Eds., American Peptide Society, San Diego, 744-745 (2002).
  67. Jung-Mo Ahn, Neil E. Jacobsen, Michael F. Brown, and Victor J. Hruby, Conformational study of [desHis1, desPhe6, Glu9]glucagon-NH2by 2D-NMR spectroscopy in the presence of perdeuterated dodecylphosphocholine. Peptides: Chemistry, Structure and Biology, Proceedings of the 17thAmerican Peptide Symposium., M. Lebl and R. A. Houghten, Eds., American Peptide Society, San Diego, 324-325 (2002).
  68. Victor J. Hruby, Jung-Mo Ahn, and Dev Trivedi, The Design and Biological Activities of Glucagon Agonists and Antagonists, and Their Use in Examining the Mechanisms of Glucose Action. Curr. Med. Chem. Imm. Endoc. & Metab. Agents 2001, 1, 199-215.
  69. Jung-Mo Ahn, Peter M. Gitu, Matthew Medeiros, Jennifer R. Swift, Dev Trivedi, and Victor J. Hruby, A New Approach to Search for the Bioactive Conformation of Glucagon: Positional Cyclization Scanning. J. Med. Chem. 2001, 44, 3109-3116.
  70. Jung-Mo Ahn, Matthew Medeiros, Dev Trivedi, and Victor J. Hruby, Development of Potent Glucagon Antagonists: Structure-Activity Relationship Study of Glycine at Position 4. J. Peptide Res.2001, 58, 151-158.
  71. Jung-Mo Ahn, Matthew Medeiros, Dev Trivedi, and Victor J. Hruby, Development of Potent Truncated Glucagon Antagonists. J. Med. Chem. 2001, 44, 1372-1379.
  72. Ying Lin, Dev Trivedi, Jung-Mo Ahn, Mara Siegel, Nevena N. Mollova, Karl H. Schram, and Victor J. Hruby, Design and Synthesis of Conformationally Constrained Glucagon Analogues. J. Med. Chem. 2000, 43, 1714-1722.
  73. S. Sturm, Y, Lin, S. K. Burley, J. L. Krstenansky, J.-M. Ahn, B. Y. Azizeh, D. Trivedi and V. J. Hruby, Structure-Function Studies on Positions 17, 18, and 21 Replacement Analogues of Glucagon: The Importance of Charged Residues and Salt Bridges in Glucagon Biological Activity. J. Med. Chem. 1998, 41, 2693-2700.
  74. Trivedi, J.-M. Ahn, J. L. Krstenansky, S. K. Burley and V. J. Hruby, Replacement at Positions 17, 18, and 21 of Glucagon Leads to Formation of a New Salt Bridge and to an Increase in Binding Affinities. Peptides: Chemistry, Structure and Biology, Proceedings of the 15thAmerican Peptide Symposium., J. P. Tam and P. T. P. Kaumaya, Eds., ESCOM Kluwer Acad. Publ., Dordrecht, The Netherlands, 619-620 (1998).
  75. Han, A. Burritt, J.-M. Ahn, and V. J. Hruby, Synthesis of beta-Methyl Aspartic Acids. Peptides: Chemistry, Structure and Biology, Proceedings of the 15thAmerican Peptide Symposium; Tam, J. P. and Kaumaya, P. T. P. Eds.; ESCOM Kluwer Acad. Publ.: Dordrecht, The Netherlands, 293-294 (1998).
  76. Victor J. Hruby, Jung-Mo Ahn, and Subo Liao, Synthesis of Oligopeptide and Peptidomimetic Libraries. Curr. Opin. Chem. Biol. 1997, 1, 114-119.
  77. Y. Azizeh, J.-M. Ahn, R. Caspari, M. D. Shenderovich, D. Trivedi, and V. J. Hruby, The Role of Phenylalanine at Position 6 in Glucagon’s Mechanim of Biological Action: Multiple Replacement Analogues of Glucagon. J. Med. Chem. 1997, 40, 2555-2562.